Key facts
- It has raised $4.0M across 1 recorded rounds; the latest was Seed Round ($4.0M) in Nov 2025.
- Notable investors include Pear (California), Keller Center's eLab, Kivanc Aydin, QNBEYOND Acceleration Program, Vicus Ventures.
- Flyway Health has filed 1 Form D with the SEC, most recently Nov 2025 ($4.0M sold to 4 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Flyway Health
Funding rounds
1 roundsAbout Flyway Health
Developer of an AI-based healthcare platform designed to revolutionize healthcare analytics through conversation-driven data exploration. The company's platform allows rapid querying of complex datasets, delivering insights on patient populations, treatment patterns, and market dynamics, enabling companies to make data-driven decisions that accelerate drug development and commercialization.
- Sector
- Information Technology
- HQ
- Wilmington, DE, United States
- Founded
- 2024
- Employees
- 5
- Website
- flywayhealth.com/
- Ownership
- Privately Held (backing)
Flyway Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Flyway Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Flyway Health in its N-PORT filings yet. We sweep new filings monthly.